MH Consulting International

05/03/2026

https://www.nzherald.co.nz/nz/politics/david-seymour-eyes-wine-style-export-boom-in-medicinal-cannabis-industry/LTLEEA4CGJH6FNMGGFM2G5NCXE/

A Cabinet paper shows more than a tonne of cannabis flower was exported in 2024.

14/08/2025

https://www.cannabiz.com.au/campaign-launched-to-amplify-patient-voices-in-tga-consultation/?utm_medium=email&utm_campaign=Cannabiz%20newsletter%20140825&utm_content=Cannabiz%20newsletter%20140825+CID_8fe9d97c11a0c975215a16f055c7c347&utm_source=CampaignMonitor&utm_term=Campaign%20launched%20to%20amplify%20patient%20voices%20in%20TGA%20consultation

The Patients campaign urges industry and patients to unite and protect access during the TGA medicinal cannabis consultation.

07/08/2025

https://www.cannabiz.com.au/july-sas-b-approvals-edge-higher-as-pastilles-share-goes-beyond-20/?utm_medium=email&utm_campaign=Cannabiz%20newsletter%20070825&utm_content=Cannabiz%20newsletter%20070825+CID_3f8ed8ab56ffc23ba0ee85059c984aad&utm_source=CampaignMonitor&utm_term=July%20SAS-B%20approvals%20edge%20higher%20as%20pastilles%20share%20rises%20beyond%2020

SAS-B approvals for medicinal cannabis rose slightly in July 2025 to 18,720, with dried flower remaining the most prescribed format.

05/07/2025

🧠✨ It’s time to bridge the gap in medical training!
Discover how the Society of Cannabis Clinicians is advocating for the inclusion of the Endocannabinoid System in medical education.

📚 Authored by SCC Board Member Shiksha Gallow and Stefan Broselid, this new study highlights why future healthcare depends on it.

Read the article following the link in our bio.

24/06/2025

18/06/2025

🌿This study followed 174 patients with drug-resistant epilepsy (DRE) treated with medical c.nn.bis. 🌿19 DRE cases experienced seizure freedom; 15 pediatric, 4 adults.

Read more: https://pubmed.ncbi.nlm.nih.gov/40458487/

28/05/2025

We’re excited to announce our intent to merge with Green Leaf Group and Elysian Group to form the brand new Helius Health - a unified health group focused on improving access, affordability, and outcomes for patients across the country.

Helius Health brings together our knowledge and capabilities with the clinical expertise of leading specialist medicinal cannabis clinics Cannabis Clinic NZ and CannaPlus+, and the dispensing capabilities of Lake Road Pharmacy.

Since medicinal cannabis was legalised five years ago, persistent challenges have hindered both patients and the regulated medical sector. By combining our strengths, Helius Health will be positioned to ensure more Kiwis can access to safe, affordable treatments, under personalised clinician-led care.

This is a huge step forward for the sector, and for patient care in New Zealand.

19/04/2025

This month marks five years since the introduction of New Zealand’s Medicinal Cannabis Scheme, a significant step forward in expanding access to regulated and quality-assured medicinal cannabis products for patients in Aotearoa.

A recent TVNZ article has drawn renewed attention to New Zealand’s evolving medicinal cannabis landscape. The piece examines the Medicinal Cannabis Scheme and explores the perspectives of patients, prescribers, and industry stakeholders.

Since the scheme’s launch, over 305,000 products have been prescribed, according to Ministry of Health data from 2024, demonstrating growing interest in medicinal cannabis as a therapeutic option. The story looks into the role of cannabis-specific clinics in supporting access while also addressing the ongoing caution among many general practitioners, a reflection of the need for continued clinical education.

The full documentary is available to view on TVNZ+ https://bit.ly/4jeCxHW

18/03/2025

🌿👩🏻‍⚕CBGA has certain efficacy in the treatment of diabetes, and glioblastoma, reducing neuroinflammation of neurodegenerative diseases and treating the side effects of chemotherapy.

Read more: https://www.cannabisclinicians.org/2025/03/14/biosynthetic-pathway-and-medical-role-of-cannabigerolic-acidbiphasic-effects-of-cannabis-and-cannabinoid-therapy-on-pain-severity-anxiety-and-sleep-disturbance-a-scoping-reviewbinge-and-cannabis-co-us/

21/02/2025

The NZ Drug Foundation has recently released an extremely useful guide surrounding workplace policy considerations for medicinal cannabis. The guide, titled “Medicinal cannabis: A guide for employers and employees”, is a significant step forward in providing patients, providers, and employers clear and concise information to understand obligations in employment. We would highly recommend a read.

The guide, and the background behind its development, can be found here: https://bit.ly/4333sRx

02/01/2025

🌿 administration in this study modulated blood concentrations of some appetitive and metabolic hormones, chiefly insulin, in cannabis users.

👉🏻 Read more: https://www.cannabisclinicians.org/2025/01/01/effects-of-oral-smoked-and-vaporized-cannabis-on-endocrine-pathways-related-to-appetite-and-metabolism-a-randomized-double-blind-placebo-controlled-human-laboratory-study/